Sellbyville, DE -- (SBWIRE) -- 05/23/2019 -- The Blood Preparation Market is set to exceed USD 78.5 billion by 2025; according to a new research report by Global Market Insights. Growing geriatric population base prone to suffer from conditions such as liver cirrhosis will act as driving factor for blood preparation market. Explosive outbreaks such as dengue fever result in high demand for blood components majorly platelets and platelet products should drive business growth. Furthermore growing awareness about blood donation and numerous initiatives undertaken by government to escalate number of blood donations should positively impact industry growth.

Surge in number of surgeries will stimulate demand for whole blood thereby fueling industry growth. Strong product pipeline of anti-coagulants along with technological advancements should propel blood preparation market growth over the forecast period. However, risk of infection post blood transfusion will hamper industry growth to certain limit over the coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/790

Anti-thrombotic and anticoagulants market is estimated to grow significantly over the analysis period to reach USD 34.0 billion by 2025. High investment made by pharmaceutical companies towards developing highly efficient and cost-effective antithrombotic drugs coupled with high incidence rate of conditions such as venous thrombosis will drive anti-thrombotic drugs market growth over the forecast timeframe. Companies are adopting inorganic growth strategies to strengthen their product portfolio. For instance, Bristol-Myers Squibb entered into strategic collaboration with Pfizer for developing and commercializing anticoagulants. Such initiatives will drive anti-coagulants market in foreseeable future.

Anti-coagulants includes heparins, vitamin K antagonists, direct thrombin inhibitors, and direct factor Xa inhibitors. Heparin dominated anti-coagulants segment by accounting more than 30% market share in 2018. High adoption of heparin injection to reduce clotting ability of blood along with its high application during bypass surgery, kidney dialysis, open-heart surgery and blood transfusions to prevent formation of blood clots should drive heparin anticoagulant market.

Pulmonary embolism application market accounted for USD 12.4 billion in 2018. Pulmonary embolism is frequent complication faced by hospitalized patients, making it one of the primary causes of preventable deaths. Anticoagulation is presently considered to be the central component for treating acute pulmonary embolism should drive pulmonary embolism anticoagulants market growth over the projection period. Unfractionated heparin or low-molecular-weight heparin along with oral vitamin K antagonists have been conventional treatment therapies for pulmonary embolism.

U.S. blood preparation market accounted for around USD 22.0 billion market size in 2018 and is estimated to witness considerable growth over the forecast timeframe. Growing number of surgeries expanded applications of blood derivatives and high awareness should drive U.S. blood preparation market. The Food & Drug Administration mandates blood centers to keep list of unsuitable donors to reduce risk of infection post blood transfusion.

Blood Preparation Market, by Application (USD Million)

1 Thrombocytosis
2 Pulmonary embolism
3 Renal impairment
4 Angina blood vessel complications

Blood Preparation Market, by Product (USD Million)

1 Blood and blood components
2 Whole blood
3 Blood components
4 Red blood cells
5 Platelets
6 Plasma
7 White blood cells

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/790

Chapter 1. Methodology

1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary

2.1. Global blood preparation industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Regional trends

Chapter 3. Blood Preparation Industry Insights

3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces

3.3.1. Growth drivers
3.3.1.1. Growing prevalence of diseases requiring blood transfusion
3.3.1.2. Rising applications of blood derivatives
3.3.1.3. Increasing awareness about blood donations in developing countries

Chapter 5. Blood Preparation Market, By Application

5.1. Key segment trends

5.2. Thrombocytosis
5.2.1. Market size, by region, 2014 - 2025

5.3. Pulmonary embolism
5.3.1. Market size, by region, 2014 – 2025

5.4. Renal impairment
5.4.1. Market size, by region, 2014 – 2025

5.5. Angina blood vessel complications
5.5.1. Market size, by region, 2014 – 2025

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/blood-preparation-market

Data Tables

TABLE 1 Blood preparation industry 3600 synopsis, 2014 – 2025
TABLE 2 Global blood preparation market, 2014 – 2018 (USD Million)
TABLE 3 Global blood preparation market, 2019 – 2025 (USD Million)
TABLE 4 Global blood preparation market, by product, 2014 - 2018 (USD Million)
TABLE 5 Global blood preparation market, by product, 2019 - 2025 (USD Million)
TABLE 6 Global blood preparation market, by blood and blood components, 2014 – 2018 (USD Million)
TABLE 7 Global blood preparation market, by blood and blood components, 2019 – 2025 (USD Million)
TABLE 8 Global blood preparation market, by anti-thrombotic and anticoagulants , 2014 – 2018 (USD Million)
TABLE 9 Global blood preparation market, by anti-thrombotic and anticoagulants, 2014 – 2018 (USD Million)
TABLE 10 Global blood preparation market, by platelet aggregation inhibitors, 2014 – 2018 (USD Million)